Skip to Main Content

Events

Tom Pack and Erica Holzer to Serve on a Panel for DRI Webinar on Preemption in Drug and Medical Device Cases

June 20, 2019

Tom Pack and Erica Holzer, attorneys in Maslon's Litigation Group, will serve on a panel for a webinar presented by DRI's Young Lawyer Committee on June 20, 2019. The webinar, titled "Preemption in Drug and Medical Device Cases: An Overview and Hot Topics," will provide a brief introduction to federal preemption, aimed at new lawyers. They will also discuss how to strategically raise the preemption defense in a variety of forums and will conclude with a forecast of where federal preemption is headed, particularly given the impending changes to the FDA's 501(k) clearance program.

Tom represents businesses in product liability matters and in other complex business litigation. He helps clients navigate all stages of the litigation process throughout many forums, including federal and state courts, mediation, and arbitration. Tom has extensive experience with discovery, including eDiscovery, and has prepared successful dispositive motions in several matters. He also has experience representing a global leading medical device manufacturer in several external medical tort matters. Additionally, Tom maintains an active pro bono practice in the civil rights and immigration law fields, with an emphasis on representing LGBTQ+ asylum seekers.

Erica represents clients in complex commercial disputes primarily in the areas of tort and product liability, consumer fraud, business torts, and breach of contract actions. Erica's product liability defense work spans many industries, with particular experience in FDA-approved medical devices, representing a major medical device manufacturer in federal and state courts throughout the country. She has also developed specialized experience providing advice and compliance support to government contractors and companies on public law issues, particularly state and federal open records laws, including the Minnesota Government Data Practices Act and the federal Freedom of Information Act.

For more information or to register, go to: DRI Webinars, "Preemption in Drug and Medical Device Cases."

DISCLAIMER

Thank you for your interest in contacting us by email.

Please do not submit any confidential information to Maslon via email on this website. By communicating with us we are not establishing an attorney-client relationship, and information you submit will not be protected by the attorney-client privilege and cannot be treated as confidential. A client relationship will not be formed until we have entered into a formal agreement. You should also be aware that we may currently represent parties whose interests may be adverse to yours, and we reserve the right to continue to represent them notwithstanding any communication we receive from you.

If you would like to discuss possible representation, please call one of our attorneys directly or use our general line (p 612.672.8200). We can then fully discuss our intake procedures and, if appropriate, introduce you to an attorney suited to assist with your matter. Alternatively, you may send us an email containing a general inquiry subject to these terms.

If you accept the terms of this notice and would like to send an email, click on the "Accept" button below. Otherwise, please click "Decline."

MEDIA INQUIRIES

We welcome the opportunity to assist you with your media inquiry. To ensure we do so properly and promptly, please feel free to contact our representative below directly by phone or via the email option provided. We look forward to hearing from you.

Emily Gurnon, Marketing Communications Manager | Office: 612.672.8251 | Mobile: 651.785.3616

EMAIL DISCLAIMER

This email is intended for use by members of the media only.

Please do not submit any confidential information to Maslon via email on this website. By communicating with us we are not establishing an attorney-client relationship, and information you submit will not be protected by the attorney-client privilege and cannot be treated as confidential. A client relationship will not be formed until we have entered into a formal agreement. You should also be aware that we may currently represent parties whose interests may be adverse to yours, and we reserve the right to continue to represent them notwithstanding any communication we receive from you.

If you would like to discuss possible representation, please call one of our attorneys directly or use our general line (p 612.672.8200). We can then fully discuss our intake procedures and, if appropriate, introduce you to an attorney suited to assist with your matter. Alternatively, you may send an email containing a general inquiry subject to these terms.

If you are a member of the media, accept the terms of this notice, and would like to send an email, click on the "Accept" button below. Otherwise, please click "Decline."